Core Insights - Kewaunee Scientific Corporation reported a 3.3% increase in sales for the third quarter of fiscal year 2026, totaling $69.4 million compared to $67.2 million in the same quarter of the previous year [1][2] - The company experienced a 25.8% increase in pre-tax earnings, reaching $1.6 million, while net earnings decreased to $692,000 from $1.4 million in the prior year [1][2] - The order backlog as of January 31, 2026, was $183.2 million, down from $221.6 million a year earlier [1] Financial Performance - Domestic sales decreased by 2.0% to $50.9 million, with net earnings from the domestic segment falling to $2.3 million from $2.9 million [1][2] - International sales increased by 21.4% to $18.4 million, with net earnings rising to $1.3 million from $476,000 in the prior year [1][2] - Corporate segment reported a pre-tax net loss of $3.1 million, slightly higher than the previous year's loss of $3.0 million [1][2] Cash and Debt Position - Total cash on hand decreased to $10.3 million from $17.2 million as of April 30, 2025 [1] - Short-term debt increased to $7.4 million from $4.8 million, while long-term debt decreased to $42.3 million from $60.7 million [1] - The debt-to-equity ratio improved to 0.68-to-1 from 0.99-to-1, indicating a stronger balance sheet [1] Strategic Initiatives - The company is focusing on integrating its newly acquired subsidiary, Nu Aire, to enhance growth and EBITDA contributions [1][2] - Investments are being made in corporate infrastructure to support future growth, including strengthening the corporate team and improving financial systems [1][2] - The CEO highlighted the importance of diversification and the resilience of the laboratory products portfolio amid challenging market conditions [1][2]

Core Insights - Kewaunee Scientific Corporation will attend the analytica 2026 tradeshow in Munich from March 24-27, showcasing its laboratory infrastructure and safety solutions alongside its subsidiary Nu Aire, Inc. [1] - The analytica trade fair is a significant global event for laboratory technology, expected to attract over 30,000 professionals and industry leaders [1] - Kewaunee and NuAire aim to demonstrate their integrated solutions and commitment to laboratory environments throughout their project lifecycle [1] Company Overview - Kewaunee Scientific Corporation, founded in 1906, specializes in the design, manufacture, and installation of laboratory and healthcare furniture products [1] - The company operates manufacturing facilities in Statesville, North Carolina, and Bangalore, India, serving both domestic and international markets [1] - Nu Aire, Inc., acquired by Kewaunee, is a manufacturer of biological safety cabinets and other laboratory products, founded in 1971 [1] Event Participation - Kewaunee and NuAire will be located at Booth B1.110 during the analytica 2026 event, where they will present their laboratory solutions [1] - The collaboration with ibs tecnomara will enhance their offerings by providing local expertise to European lab planners and end users [1] - The showcased products will include Class II biosafety cabinets, controlled environment systems, adaptable bench systems, and energy-efficient fume hoods [1]

Core Viewpoint - Kewaunee Scientific Corporation plans to release its third quarter fiscal year 2026 financial results on March 11, 2026, after trading hours [1] Company Overview - Kewaunee Scientific Corporation, founded in 1906, is a global leader in designing, manufacturing, and installing laboratory, healthcare, and technical furniture products [1] - The company offers a range of products including steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks [1] - Corporate headquarters are located in Statesville, North Carolina, with sales offices in the United States, India, Saudi Arabia, and Singapore [1] - Kewaunee operates three manufacturing facilities in Statesville and one in Bangalore, India, serving both domestic and international markets [1] Recent Acquisition - Kewaunee Scientific's newly acquired subsidiary, Nu Aire, specializes in manufacturing biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products [1] - Nu Aire was founded in 1971 and has its headquarters and manufacturing facilities in Plymouth, Minnesota, with additional capabilities in Long Lake, Minnesota, and a warehouse partnership in the Netherlands [1]

Core Viewpoint - Kewaunee Scientific Corporation has successfully refinanced its debt and fully repaid its Seller Notes ahead of schedule, reflecting strong financial performance and strategic capital management [2][4]. Debt Refinancing - The company repaid its Seller Notes, which had an original outstanding principal balance of $23.0 million, ahead of the November 1, 2027 maturity date [2]. - This repayment was partially funded by a $10.0 million term loan from PNC Bank and the use of available funds from its revolving line of credit [2][3]. Financial Impact - The refinancing has led to a reduction in the overall debt load and a decrease in the effective interest rate on the company's debt portfolio, which is expected to lower future interest expenses [3][4]. - The company attributes its ability to repay the Seller Notes early to consistent financial performance from its legacy business and contributions from the newly acquired Nu Aire business [4]. Strategic Positioning - The refinancing provides the company with flexibility to execute key strategic initiatives aimed at driving future organic and inorganic growth, ultimately generating value for shareholders [4]. Company Overview - Kewaunee Scientific Corporation, founded in 1906, is a global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products [5]. - The company operates manufacturing facilities in Statesville, North Carolina, and Bangalore, India, serving both domestic and international markets [5]. - The newly acquired subsidiary, Nu Aire, specializes in laboratory products such as biological safety cabinets and CO2 incubators, complementing Kewaunee's existing portfolio [5].

Core Viewpoint - Kewaunee Scientific Corporation plans to release its second quarter fiscal year 2026 financial results on December 10, 2025, after trading hours [1] Company Overview - Kewaunee Scientific Corporation, founded in 1906, is a global leader in designing, manufacturing, and installing laboratory, healthcare, and technical furniture products [2] - The company's product offerings include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks [2] - The corporate headquarters is located in Statesville, North Carolina, with sales offices in the United States, India, Saudi Arabia, and Singapore [2] - Kewaunee operates three manufacturing facilities in Statesville and one in Bangalore, India, serving both domestic and international markets [2] - The recently acquired subsidiary, Nu Aire, specializes in biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products, enhancing Kewaunee's portfolio [2] Additional Information - The company maintains a warehouse partnership in the Netherlands and OEM partnerships in China [2] - For further details, Kewaunee Scientific's and Nu Aire's websites are available for reference [3]

Core Insights - Kewaunee Scientific Corporation will participate in the 2025 Arablab Live tradeshow and conference in Dubai from September 23-25 [1] - The company will showcase its integrated expertise in laboratory infrastructure, biosafety, and healthcare environments, alongside its newly acquired subsidiary NuAire and healthcare brand EVERHUTCH [2][4] Company Overview - Kewaunee Scientific Corporation, founded in 1906, is a global leader in designing, manufacturing, and installing laboratory and healthcare furniture products [5] - The company operates manufacturing facilities in Statesville, North Carolina, and Bangalore, India, serving both domestic and international markets [5] Product Offerings - Kewaunee's product range includes steel and wood casework, fume hoods, biological safety cabinets, and epoxy resin work surfaces [5] - The company will highlight its new Revit design tools at the Arablab tradeshow, aimed at enhancing lab planning and architectural precision [3] Subsidiary Information - NuAire, acquired by Kewaunee, specializes in biological safety cabinets and other essential laboratory products, with manufacturing facilities in Minnesota and partnerships in the Netherlands and China [6]

Company Overview - Kewaunee Scientific Corporation, founded in 1906, is a global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products [2] - The company's product offerings include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks [2] - Kewaunee's corporate headquarters is located in Statesville, North Carolina, with sales offices in the United States, India, Saudi Arabia, and Singapore [2] - The company operates three manufacturing facilities in Statesville and one in Bangalore, India, serving both domestic and international markets [2] Recent Developments - Kewaunee Scientific announced plans to release its first quarter fiscal year 2026 financial results on September 10, 2025, after the close of trading [1] - The newly acquired subsidiary, Nu Aire, specializes in manufacturing biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products [3] - Nu Aire, founded in 1971, has its headquarters and manufacturing facilities in Plymouth, Minnesota, with additional capabilities in Long Lake, Minnesota, and a warehouse partnership in the Netherlands [3] Future Outlook - The company is focused on realizing the benefits of the Nu Aire acquisition, which is expected to enhance its product portfolio and market reach [5]

Core Viewpoint - Kewaunee Scientific Corporation (KEQU) has received an upgrade to "Outperform" due to strong acquisition execution, sustained margin improvement, a record backlog providing revenue visibility, and partial insulation from macroeconomic challenges through healthcare exposure [1]. Acquisition Execution & Strategic Fit - The acquisition of Nu Aire, Inc. in November 2024 has resulted in a 30.7% year-over-year increase in domestic segment sales, reaching $179.4 million in fiscal 2025 [2]. - This acquisition has expanded KEQU's product portfolio to include higher-margin products like biological safety cabinets, CO2 incubators, and ultralow freezers, while also establishing new distribution partners in previously underpenetrated markets [3]. - Integration progress has exceeded expectations, creating early cross-selling opportunities and reinforcing KEQU's position as a full-spectrum laboratory solutions provider [3]. Gross Margin Expansion & Profitability Gains - KEQU's gross margin has expanded by 310 basis points to 28.6% in fiscal 2025 from 25.5% in fiscal 2024, driven by Nu Aire's favorable product mix, operational efficiencies, and disciplined cost control, despite incurring $6 million in one-time integration and purchase accounting expenses [4]. - Adjusted EBITDA increased by 28.4% to $26.5 million, representing 10.9% of sales, indicating the company's ability to convert top-line gains into higher operating leverage [5]. - The annuitization of the company's pension obligation in fiscal 2024 has reduced earnings volatility, providing a cleaner base for future margin expansion [5]. Record Backlog & Revenue Visibility - KEQU has a record backlog of $214.6 million at the end of fiscal 2025, up 37.9% from the previous year, providing exceptional near-term revenue visibility, with management expecting 93% of orders to convert into revenues in fiscal 2026 [6]. - The backlog includes diverse end markets such as healthcare, pharmaceuticals, and education, which helps mitigate cyclicality often seen in the broader construction and industrial sectors [6]. - The healthcare and life sciences sectors, enhanced by Nu Aire's capabilities, have shown greater resilience against macroeconomic uncertainty, providing KEQU with a degree of macro immunity [7]. Conclusion - Kewaunee's transformation following the Nu Aire acquisition, along with strong domestic performance, expanding margins, record backlog, and attractive valuation, supports an Outperform rating [10]. - The company is positioned to deliver above-market returns over the next 12 months, with key catalysts including backlog conversion and incremental synergies from the Nu Aire integration [10].